Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Linda Mileshkin

Showing results (101-110 of 174) with videos related to

Pageof 18
Sort By:
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 25, 2014
Gynecologic Cancer InterGroup (GCIG) consensus review for ovarian and primary peritoneal low-grade serous carcinomasCharlie Gourley, John Farley, Diane M Provencher, et al.
The Journal of Pathology|September 17, 2013
Massively-parallel sequencing assists the diagnosis and guided treatment of cancers of unknown primaryRichard W Tothill, Jason Li, Linda Mileshkin, et al.
British Journal of Cancer|July 20, 2023
Pamiparib in combination with tislelizumab in patients with advanced solid tumours: results from the dose-expansion stage of a multicentre, open-label, phase I trialMichael Friedlander, Linda Mileshkin, Janine Lombard, et al.
ESMO Open|December 2, 2020
Impact of COVID-19 on cancer service delivery: results from an international survey of oncology cliniciansGrace Chazan, Fanny Franchini, Marliese Alexander, et al.
Blood|March 15, 2003
Multicenter phase 2 trial of thalidomide in relapsed/refractory multiple myeloma: adverse prognostic impact of advanced ageLinda Mileshkin, James J Biagi, Paul Mitchell, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 25, 2014
Gynecologic Cancer InterGroup (GCIG) consensus review for small cell carcinoma of the cervixToyomi Satoh, Yuji Takei, Isabelle Treilleux, et al.
JCO Precision Oncology|January 7, 2022
Cancer Diagnoses Following Abnormal Noninvasive Prenatal Testing: A Case Series, Literature Review, and Proposed Management ModelEryn Dow, Alison Freimund, Kortnye Smith, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 3, 2011
Changes in 18F-fluorodeoxyglucose and 18F-fluorodeoxythymidine positron emission tomography imaging in patients with non-small cell lung cancer treated with erlotinibLinda Mileshkin, Rodney J Hicks, Brett G M Hughes, et al.
European Journal of Cancer (Oxford, England : 1990)|October 11, 2023
Modified study designs to expand treatment options in personalised oncology: a multistakeholder viewChristophe Le Tourneau, Fabrice André, Åslaug Helland, et al.
Journal for Immunotherapy of Cancer|November 16, 2021
Combination immunotherapy with nivolumab and ipilimumab in patients with rare gynecological malignancies: results of the CA209-538 clinical trialOliver Klein, Damien Kee, Bo Gao, et al.
Pageof 18

Showing results (101-110 of 174) with videos related to

Sort By:
Pageof 18
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 25, 2014
Gynecologic Cancer InterGroup (GCIG) consensus review for ovarian and primary peritoneal low-grade serous carcinomasCharlie Gourley, John Farley, Diane M Provencher, et al.
The Journal of Pathology|September 17, 2013
Massively-parallel sequencing assists the diagnosis and guided treatment of cancers of unknown primaryRichard W Tothill, Jason Li, Linda Mileshkin, et al.
British Journal of Cancer|July 20, 2023
Pamiparib in combination with tislelizumab in patients with advanced solid tumours: results from the dose-expansion stage of a multicentre, open-label, phase I trialMichael Friedlander, Linda Mileshkin, Janine Lombard, et al.
ESMO Open|December 2, 2020
Impact of COVID-19 on cancer service delivery: results from an international survey of oncology cliniciansGrace Chazan, Fanny Franchini, Marliese Alexander, et al.
Blood|March 15, 2003
Multicenter phase 2 trial of thalidomide in relapsed/refractory multiple myeloma: adverse prognostic impact of advanced ageLinda Mileshkin, James J Biagi, Paul Mitchell, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 25, 2014
Gynecologic Cancer InterGroup (GCIG) consensus review for small cell carcinoma of the cervixToyomi Satoh, Yuji Takei, Isabelle Treilleux, et al.
JCO Precision Oncology|January 7, 2022
Cancer Diagnoses Following Abnormal Noninvasive Prenatal Testing: A Case Series, Literature Review, and Proposed Management ModelEryn Dow, Alison Freimund, Kortnye Smith, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 3, 2011
Changes in 18F-fluorodeoxyglucose and 18F-fluorodeoxythymidine positron emission tomography imaging in patients with non-small cell lung cancer treated with erlotinibLinda Mileshkin, Rodney J Hicks, Brett G M Hughes, et al.
European Journal of Cancer (Oxford, England : 1990)|October 11, 2023
Modified study designs to expand treatment options in personalised oncology: a multistakeholder viewChristophe Le Tourneau, Fabrice André, Åslaug Helland, et al.
Journal for Immunotherapy of Cancer|November 16, 2021
Combination immunotherapy with nivolumab and ipilimumab in patients with rare gynecological malignancies: results of the CA209-538 clinical trialOliver Klein, Damien Kee, Bo Gao, et al.
Pageof 18